Clinical trialNCT02207530CompletedPhase 2Interventional

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

SponsorAstraZenecaEnrollment112Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dan Paul Zandberg, MD
International Coordinating Investigator
Principal Investigator
clinicaltrials.gov ↗
Magdalena Wrona
Medical Scientist AstraZeneca Magdalena.Wrona@astrazeneca.com
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

108 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Research Site
Brussels, Belgium
Research Site
Kortrijk, Belgium
Research Site
Leuven, Belgium
Research Site
Montigny-le-Tilleul, Belgium
Research Site
Namur, Belgium

Canada

Research Site
Calgary, Alberta, Canada
Research Site
London, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada

Czechia

Research Site
Zlín, Czechia

France

Research Site
Angers, France
Research Site
Bordeaux, France
Research Site
Brest, France
Research Site
Clermont-Ferrand, France
Research Site
Dijon, France
Research Site
Le Mans, France
Research Site
Lille, France
Research Site
Lorient, France
Research Site
Lyon, France
Research Site
Montpellier, France
Research Site
Nice, France
Research Site
Plerin SUR MER, France
Research Site
Rouen, France
Research Site
Saint-Grégoire, France
Research Site
Strasbourg, France
Research Site
Toulouse, France
Research Site
Villejuif, France

Georgia

Research Site
Batumi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia

Germany

Research Site
Berlin, Germany
Research Site
Halle, Germany
Research Site
Heidelberg, Germany
Research Site
Leipzig, Germany
Research Site
München, Germany

Hungary

Research Site
Budapest, Hungary
Research Site
Budapest, Hungary
Research Site
Gyula, Hungary

68 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 23 Oct 2014
Primary completion: 26 Sept 2016
Completion: 6 Jul 2020
Last update posted: 29 Sept 2020
Registered enrollment: 112
Registry id: NCT02207530

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.